CITIUS PHARMACEUTICALS INC (CTXR)
US17322U2078 - Common Stock
ChartMill assigns a Buy % Consensus number of 82% to CTXR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.44. This target is 621.1% above the current price.
CTXR was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about CTXR.
In the previous month the buy percentage consensus was at a similar level.
CTXR was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-02-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-01 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-05-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-04-03 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-29 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-01-18 | HC Wainwright & Co. | Maintains | Buy |
| 2021-11-30 | Maxim Group | Initiate | Buy |